Abstract
Multiple sclerosis (MS) is an autoimmune neurological disorder of unknown etiology. Oxidative stress and alterations in vitamin D levels have been implicated in the pathophysiology of MS. The aim of this study was to investigate δ-aminolevulinate dehydratase (δ-ALA-D) activity as well as the levels of vitamin D, lipid peroxidation levels, carbonyl protein content, DNA damage, superoxide dismutase (SOD) and catalase (CAT) activities, and the vitamin C, vitamin E, and non-protein thiol (NPSH) content in samples from patients with the relapsing-remitting form of MS (RRMS). The study population consisted of 29 RRMS patients and 29 healthy subjects. Twelve milliliters of blood was obtained from each individual and used for biochemical determinations. The results showed that δ-ALA-D and CAT activities were significantly increased, while SOD activity was decreased in the whole blood of RRMS patients compared to the control group (P < 0.05). In addition, we observed a significant increase in lipid peroxidation, carbonyl protein levels in serum and damaged DNA in leucocytes in RRMS patients compared with the control group (P < 0.05). Nonetheless, the levels of vitamin C, vitamin E, NPSH, and vitamin D were significantly decreased in RRMS patients in relation to the healthy individuals (P < 0.05). In conclusion, our results suggested that the increase in δ-ALA-D activity may be related to the inflammatory and immune process in MS in an attempt to maintain the cellular metabolism and reduce oxidative stress. Moreover, the alterations in the oxidant/antioxidant balance and lower vitamin D levels may contribute to the pathophysiology of MS.
Similar content being viewed by others
References
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126
Allen AC, Kelly S, Basdeo SA, Kinsella K, Mulready KJ, Mills KH, Tubridy N, Walsh C, Brady JJ, Hutchinson M, Fletcher JM (2012) A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers. Mult Scler 18:1797–1800
Ascherio A, Munger KL, Lünemann JD (2012) The initiation and prevention of multiple sclerosis. Nat Rev Neurol 8:602–612
Benhusein GM, Mutch E, Aburawi S, Williams FM (2010) Genotoxic effect induced by hydrogen peroxide in human hepatoma cells using comet assay. Libyan J Med 5:1–6
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Correale J, Ysrraelit MC, Gaitán MI (2009) Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132:1146–1160
Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A (2003) Protein carbonylation in human diseases. Trends Mol Med 9:169–176
Djordjević VB, Zvezdanović L, Cosić V (2008) Oxidative stress in human diseases. Srp Arh Celok Lek 136:158–165
Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77
Fialkow L, Wang Y, Downey GP (2007) Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 42:153–164
Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal in multiple sclerosis. Nat Rev Neurol 10:225–238
Gianforcaro A, Hamadeh MJ (2014) Vitamin D as a potential therapy in amyotrophic lateral sclerosis. CNS Neurosci Ther 20:101–111
Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251:261–268
Gonsette RE (2008) Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci 274:48–53
Gonzalo H, Brieva L, Tatzber F, Jové M, Cacabelos D, Cassanyé A, Lanau-Angulo L, Boada J, Serrano JC, González C, Hernández L, Peralta S, Pamplona R, Portero-Otin M (2012) Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism. J Neurochem 123:622–634
Grecchi S, Mazzini G, Lisa A, Armentero MT, Bergamaschi R, Romani A, Blandini F, Di Perri C, Scovassi AI (2012) Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study. PLoS One 7:e44935
Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF (2013) Vitamin D: update 2013: from rickets prophylaxis to general preventive healthcare. Dermatoendocrinol 5:331–347
Haider L, Fischer MT, Frischer JM, Bauer J, Ho¨ftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H (2011) Oxidative damage in multiple sclerosis lesions. Brain 134:1914–1924
Halliwell B (2012) Free radicals and antioxidants: updating a personal view. Nutr Rev 70:257–265
Han X, Zhou DB, Xu CM, Yang Y, Duan MH, Wang X, Zhang JP, Zhao YQ, Shen T, Wu YJ (2011) Effect of erythropoietin on proinflammatory factors of human monocytes and its mechanisms. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19(3):738–743
Hansen LG, Warwick WJ (1969) A fluorometric micromethod for serum vitamins A and E. Tech Bull Regist Med Technol 39:70–73
Hanwell HEC, Banwell B (2011) Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim Biophys Acta 1812:202–212
Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, Collins A, Smith A, Speit G, Thybaud V, Tice RR (2003) Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis 18:45–51
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930
Jacques-Silva MC, Nogueira CW, Broch LC, Flores EM, Rocha JB (2001) Diphenyl diselenide and ascorbic acid changes deposition of selenium and ascorbic acid in liver and brain of mice. Pharmacol Toxicol 88:119–125
Jentzsch AM, Bachmann H, Fürst P, Biesalski HK (1996) Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20:251–256
Johansson SV, Strandberg PO (1972) Haem biosynthesis studied in patients with rheumatoid arthritis. J Clin Pathol 25:159–162
Johnson F, Giulivi C (2005) Superoxide dismutases and their impact upon human health. Mol Aspects Med 26:340–352
Kang Z, Zhang J, Zhou J, Qi Q, Du G, Chen J (2012) Recent advances in microbial production of δ-aminolevulinic acid and vitamin B12. Biotechnol Adv 30:1533–1542
Koch M, Ramsaransing GS, Arutjunyan AV, Stepanov M, Teelken A, Heersema DJ, De Keyser J (2006) Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. J Neurol 253:483–487
Kopff M, Zakrzewska I, Czernicki J, Klem J, Strzelczyk M (1993) Red cell superoxide dismutase and catalase activity in multiple sclerosis. Acta Biochim Pol 40:154–157
Lassmann H, van Horssen J (2011) The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 585:3715–3723
Lee DH, Gold R, Linker RA (2012) Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters. Int J Mol Sci 13:11783–11803
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478
Li-Weber M, Weigand MA, Giaisi M, Süss D, Treiber MK, Baumann S, Ritsou E, Breitkreutz R, Krammer PH (2002) Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J Clin Invest 110:681–690
Ljubisavljevic S, Stojanovic I, Vojinovic S, Stojanov D, Stojanovic S, Kocic G, Savic D, Cvetkovic T, Pavlovic D (2013) Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic. Cell Mol Neurobiol 33:767–777
Ljubisavljevic S, Stojanovic I, Cvetkovic T, Vojinovic S, Stojanov D, Stojanovic D, Stefanovic N, Pavlovic D (2014) Erythrocytes’ antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation. J Neurol Sci 337:8–13
Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JŠ, Torkildsen Ø, Wergeland S, Holmøy T (2013) Alpha-tocopherol and MRI outcomes in multiple sclerosis—association and prediction. PLoS One 8:e54417
Mao P, Reddy PH (2010) Is multiple sclerosis a mitochondrial disease? Biochim Biophys Acta 1802:66–79
Matés JM, Sánchez-Jiménez F (1999) Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 4:D339–D345
Mazza M, Pomponi M, Janiri L, Bria P, Mazza S (2007) Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog Neuropsychopharmacol Biol Psychiatry 31:12–26
McCaddon A (2013) Vitamin B12 in neurology and ageing; clinical and genetic aspects. Biochimie 95:1066–1076
McCord JM, Edeas MA (2005) SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother 59:139–142
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
McKelvey-Martin VJ, Green MH, Schmezer P, Pool-Zobel BL, De Méo MP, Collins A (1993) The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 288:47–63
Miller E, Mrowicka M, Malinowska K, Zołyński K, Kedziora J (2010) Effects of the whole-body cryotherapy on a total antioxidative status and activities of some antioxidative enzymes in blood of patients with multiple sclerosis-preliminary study. J Med Invest 57:168–173
Miller E, Walczak A, Majsterek I, Kędziora J (2013) Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. J Neuroimmunol 257:97–101
Mirshafiey A, Mohsenzadegan M (2009) Antioxidant therapy in multiple sclerosis. Immunopharmacol Immunotoxicol 31:13–29
Misra HP, Fridovich I (1972) The role of superoxide anion in autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3175
Mitosek-Szewczyk K, Gordon-Krajcer W, Walendzik P, Stelmasiak Z (2010) Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy. Folia Neuropathol 48:116–122
Mora JR, Iwata M, von Andrian UH (2008) Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8:685–698
Morelli A, Ravera S, Calzia D, Panfoli I (2012) Impairment of heme synthesis in myelin as potential trigger of multiple sclerosis. Med Hypotheses 78:707–710
Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60–65
Nadin SB, Vargas-Roig LM, Ciocca DR (2001) A silver staining method for single-cell gel assay. J Histochem Cytochem 49:1183–1186
Ortiz GG, Pacheco-Moisés FP, Bitzer-Quintero OK, Ramírez-Anguiano AC, Flores-Alvarado LJ, Ramírez-Ramírez V, Macias-Islas MA, Torres-Sánchez ED (2013) Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Clin Dev Immunol 2013:708659
Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y (2005) Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab 23:309–313
Padh H (2005) Vitamin C: newer insights into its biochemical functions. Cell Mol Biol Lett 10:255–264
Paniz C, Bairros A, Valentini J, Charão M, Bulcão R, Moro A, Grune T, Garcia SC (2007) The influence of the serum vitamin C levels on oxidative stress biomarkers in elderly women. Clin Biochem 40:1367–1372
Pasquali L, Pecori C, Lucchesi C, LoGerfo A, Iudice A, Siciliano G, Bonuccelli U (2015) Plasmatic oxidative stress biomarkers in multiple sclerosis: relation with clinical and demographic characteristics. Clin Biochem 48:19–23
Pekmezci D (2011) Vitamin E and Immunity. Vitam Horm 86:179–215
Pierrot-Deseilligny C, Souberbielle JC (2013) Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Ther Adv Neurol Disord 6:81–116
Polachini CR, Spanevello RM, Casali EA, Zanini D, Pereira LB, Martins CC, Baldissareli J, Cardoso AM, Duarte MF, da Costa P, Prado AL, Schetinger MR, Morsch VM (2014) Alterations in the cholinesterase and adenosine deaminase activities and inflammation biomarker levels in patients with multiple sclerosis. Neuroscience 266:266–274
Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, Deluca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC (2009) Expression of the multiple sclerosis associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 5:e1000369
Ransohoff RM, Hafler DA, Lucchinetti CF (2015) Multiple sclerosis-a quiet revolution. Nat Rev Neurol 11:134–142
Reinhardt K, Weiss S, Rosenbauer J, Gartnera J, von Kries R (2014) Multiple sclerosis in children and adolescents: incidence and clinical picture—new insights from the nationwide German surveillance (2009–2011). Eur J Neurol 21:654–659
Reynolds R, Roncaroli F, Nicholas R, Radotra B, Gveric D, Howell O (2011) The neuropathological basis of clinical progression in multiple sclerosis. Acta Neuropathol 122:155–170
Ricciarelli R, Argellati F, Pronzato MA, Domenicotti C (2007) Vitamin E and neurodegenerative diseases. Mol Aspects Med 28:591–606
Rocha ME, Dutra F, Bandy B, Baldini RL, Gomes SL, Faljoni-Alario A, Liria CW, Miranda MT, Bechara EJ (2003) Oxidative damage to ferritin by 5-aminolevulinic acid. Arch Biochem Biophys 409:349–365
Rocha JBT, Saraiva RA, Garcia SC, Gravina FS, Nogueira CW (2012) Aminolevulinate dehydratase (δ-ALA-D) as marker protein of intoxication with metals and other pro-oxidant situations. Toxicol Res 1:85–102
Rommer PS, Greilberger J, Salhofer-Polanyi S, Auff E, Leutmezer F, Herwig R (2014) Elevated levels of carbonyl proteins in cerebrospinal fluid of patients with neurodegenerative diseases. Tohoku J Exp Med 234:313–317
Sadowska-Bartosz I, Adamczyk-Sowa M, Galiniak S, Mucha S, Pierzchala K, Bartosz G (2013) Oxidative modification of serum proteins in multiple sclerosis. Neurochem Int 63:507–516
Salemi G, Gueli MC, Vitale F, Battaglieri F, Guglielmini E, Ragonese P, Trentacosti A, Massenti MF, Savettieri G, Bono A (2010) Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. Lipids Health Dis 9:19
Sassa S (1982) Delta-aminolevulinic acid dehydratase assay. Enzyme 28:133–145
Sassa S (1998) ALAD porphyria. Semin Liver Dis 18:95–101
Schmatz R, Perreira LB, Stefanello N, Mazzanti C, Spanevello R, Gutierres J, Bagatini M, Martins CC, Abdalla FH, da Silva Daci, Serres J, Zanini D, Vieira JM, Cardoso AM, Schetinger MR, Morsch VM (2012) Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 94:374–383
Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68:193–203
Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191
Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R (2008) Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 14:1220–1224
Souza JB, Rocha JB, Nogueira CW, Borges VC, Kaizer RR, Morsch VM, Dressler VL, Martins AF, Flores EM, Schetinger MR (2007) Delta-aminolevulinate dehydratase (δ-ALA-D) activity in diabetes and hypothyroidism. Clin Biochem 40:321–325
Tavazzi B, Batocchi AP, Amorini AM, Nociti V, D’Urso S, Longo S, Gullotta S, Picardi M, Lazzarino G (2011) Serum metabolic profile in multiple sclerosis patients. Mult Scler Int 2011:167156
Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247–269
Valentini J, Grotto D, Paniz C, Roehrs M, Burg G, Garcia SC (2008) The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients. Biomed Pharmacother 62:378–382
van Horssen J, Schreibelt G, Drexhage J, Hazes T, Dijkstra CD, van der Valk P, de Vries HE (2008) Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic Biol Med 45:1729–1737
van Horssen J, Witte ME, Schreibelt G, Helga E, de Vries HE (2011) Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta 1812:141–150
Van Laer K, Hamilton CJ, Messens J (2013) Low-molecular-weight thiols in thiol-disulfide exchange. Antioxid Redox Signal 18:1642–1653
Villacorta L, Azzi A, Zingg JM (2007) Regulatory role of vitamins E and C on extracellular matrix components of the vascular system. Mol Aspects Med 8:507–537
Wacker M, Holick MF (2013) Vitamin D effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 5:111–148
Yousefi B, Ahmadi Y, Ghorbanihaghjo A, Faghfoori Z, Irannejad VS (2014) Serum arsenic and lipid peroxidation levels in patients with multiple sclerosis. Biol Trace Elem Res 158:276–279
Zanini D, Pelinson LP, Schmatz R, Belmonte PL, Curry MC, Baldissareli J, Pires AG, Antunes SFA, Brenner RLG, Araújo MC, Chiesa J, Morsch VM, Bitencourt RLD, Schetinger MR (2014) δ-Aminolevulinate dehydratase activity in lung cancer patients and its relationship with oxidative stress. Biomed Pharmacother 68:603–609
Acknowledgments
The authors wish to thank the neurologist Juarez Lopes and the MS patients and healthy subjects that contributed to the realization of this study. We also thank the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Rio Grande do Sul (FAPERGS), FAPERGS/PPSUS 1279-2551/13-7, Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Instituto Brasileiro de Neurociência (IBN-Net), INCT for Excitotoxicity and Neuroprotection, and the Federal University of Santa Maria, RS, Brazil for financial support.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
This work is original and is not under consideration by another journal. All of the patients provided written consent, and the work was approved by the Human Ethical Committee from the Federal University of Santa Maria Hospital. Finally, this manuscript has been approved by all of the authors, and none of the authors have a conflict of interest.
Rights and permissions
About this article
Cite this article
Polachini, C.R.N., Spanevello, R.M., Zanini, D. et al. Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis. Neurotox Res 29, 230–242 (2016). https://doi.org/10.1007/s12640-015-9584-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-015-9584-2